Pool9_POS_RA2_1_5955.cdf
Estelle Pujos‐Guillot, Francine Béhar‐Cohen · Recherche Data Gouv France · 2026
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Recherche Data Gouv France · OpenAlex · dataset · 2026
Abstract
Central serous chorioretinopathy (CSCR) is the fourth most common cause of chorioretinal disease, affecting predominantly males. The most established risk factor for CSCR is systemic exposure to glucocorticoids through mechanisms that remain unclear. Untargeted systemic metabolomics was analyzed in 60 men with CSCR and age-matched controls using UHPLC-MS. The analysis revealed a total of 722 metabolites that differed significantly between the CSCR and control groups, with 592 being downregulated and 130 being upregulated.
The metabolic profile exhibited incomplete breakdown products of protein digestion or catabolism, incomplete fatty acid β-oxidation, and alterations in antioxidant metabolism. Additionally, it revealed changes in pathways involved in amino acid and derivative metabolism, which have implications for the immune system and inflammation. Furthermore, a substantial upregulation of three primary fatty acid amides was observed, along with a downregulation of long-chain acylcarnitines and kynurenines.
The reduction in long and medium chain acylcarnitine, S1P, tryptophan, and kynurenine, all of which are upregulated by glucocorticoids, does not support the hypothesis of glucocorticoid excess in patients with CSCR. In conclusion, we report here that patients with CRSC present a metabolic signature that could be useful as a complement to specific endocrine studies to better understand the relationship between corticoids and the pathology. Repeated cohorts are needed to validate these findings.
Open the resolved locator · 10.57745/esebit
Metadata licence: OpenAlex metadata (CC0)